Moreover, CODEX analysis of orthotopic mouse mammary tumors demonstrated that inhibiting S100A7/cPLA2 signaling increased the abundance of proliferating as well as activated CD4+ and CD8+ TILs. This evidence concerns the gene S100A7 and breast cancer.